Value Added Technology Co., Ltd. (KOSDAQ:043150)
19,650
+570 (2.99%)
Jun 12, 2026, 3:30 PM KST
Value Added Technology Revenue
Value Added Technology had revenue of 105.20B KRW in the quarter ending March 31, 2026, with 3.83% growth. This brings the company's revenue in the last twelve months to 430.30B, up 9.69% year-over-year. In the year 2025, Value Added Technology had annual revenue of 426.42B with 10.70% growth.
Revenue (ttm)
430.30B
Revenue Growth
+9.69%
P/S Ratio
0.66
Revenue / Employee
1.48B
Employees
290
Market Cap
283.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 426.42B | 41.22B | 10.70% |
| Dec 31, 2024 | 385.19B | 249.51M | 0.06% |
| Dec 31, 2023 | 384.95B | -10.11B | -2.56% |
| Dec 31, 2022 | 395.06B | 56.08B | 16.54% |
| Dec 31, 2021 | 338.98B | 94.67B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 718.78B |
| CLASSYS | 346.88B |
| Vieworks | 243.11B |
| T&L Co., Ltd. | 157.91B |
| BioNote | 122.44B |
| Dongbang Medical | 117.37B |
| Shinhung | 104.15B |
| PCL, Inc. | 4.98B |
Value Added Technology News
- 4 weeks ago - Value Added Technology Slides: Q1 2026 - Filings
- 3 months ago - Value Added Technology Annual report: Q4 2025 - Filings
- 3 months ago - Value Added Technology Slides: Q4 2025 - Filings
- 7 months ago - Value Added Technology Slides: Q3 2025 - Filings
- 10 months ago - Value Added Technology Slides: Q2 2025 - Filings